Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1255results about "Haemofiltration" patented technology

Thrombectomy methods

Methods for aspiration to remove thrombus / clot material using a system configured to remove, filter and return clot. These methods allow the removal of clot material using a fluidically-driven aspiration device when attached to an aspiration catheter and proximate to obstructive clot material. A fluidic actuator drives an aspirator, which may be automatically controlled to apply a vacuum in a pattern to enhance clot removal and collection from the body as well as improve blood return using the same closed system. The fluidic actuator may direct the aspirated blood through a filter and deaerator to allow the filtered blood to be returned to the patient.
Owner:INQUIS MEDICAL INC

Membrane coated with polydopamine and chondroitin and process for producing same

The present disclosure relates to a membrane prepared from a blend comprising i) a polysulfone, polyether sulf one or polyarylethersulfone and ii) polyvinylpyrrolidone, characterized in that the membrane is coated with polydopamine and chon-droitin. Optionally the coating further comprises heparin. The disclosure further relates to a process for producing the coated membrane, a method of increasing the selectivity of a membrane, and to a filtration / diffusion device comprising the membrane which can be used, for example, in hemodialysis applications.
Owner:GAMBRO LUNDIA AB

Disposable components for fluid line autoconnect systems and methods

Components for a medical infusion fluid handling system, such as an APD system, in which one or more lines (such as solution lines), spikes or other connection ports may be automatically capped and / or de-capped. This feature may provide advantages, such as a reduced likelihood of contamination since no human interaction is required to de-cap and connect the one or more lines, the spikes, or the other connection ports. For example, a fluid handling cassette may include one or more caps that cover a corresponding spike and include a raised and / or recessed feature to assist in removal of the one or more caps from the cassette. A solution line cap may include a hole and a recess, a groove or other feature to engage with a spike cap and enable removal of the spike cap.
Owner:DEKA PRODUCTS LP

Compositions and methods for plasmapheresis

Described herein are compositions and methods for performing plasmapheresis. The compositions and methods for performing plasmapheresis are innovative at least in their application towards the treatment and prevention of aging and conditions associated with aging. Plasmapheresis compositions and methods described herein are directed towards reducing or eliminating conditions associated with aging.
Owner:VIOME CIRCULATE LLC

Clazakizumab in the Treatment of Chronic Antibody-Mediated Rejection of Organ Transplant

Described herein are methods for treating antibody mediated rejection (ABMR), especially chronic active ABMR (cABMR), of transplanted organs using clazakizumab. Human kidney transplant recipients with biopsy-proven cABMR, transplant glomerulopathy and who are donor-specific antibody positive showed stabilization of renal function and lowered DSA levels following clazakizumab treatment. The estimated glomerular filtration rate of the patients at six, 12 or even 18 months were stabilized, inflammatory markers of cABMR were reduced or stabilized, and inflammatory blood markers were reduced, since clazakizumab treatment.
Owner:CEDARS SINAI MEDICAL CENT

Device for monitoring blood purification using an extracorporeal blood purification device

The invention relates to a method and a device for monitoring blood purification with an extracorporeal blood purification device which is designed such that a blood purification unit 1 is used to perform blood purification with predetermined treatment parameters Qb in an extracorporeal blood circuit 9. The concentration of a substance is measured during the blood purification with at least one sensor 31, 32, 33, 34 and a parameter K which is characteristic of the purifying performance of the blood purification unit 1 is determined with a computing and / or evaluation unit 25 on the basis of the measured concentration of a substance. The parameter K which is characteristic of the purifying performance of the blood purification unit 1 is compared with an expected value Kref. To this end, a tolerance range is determined for the expected value using the computing and / or evaluation unit 25, wherein actions that are predetermined by the computing and / or evaluation unit 25 are triggered depending on whether the parameter which is characteristic of the purifying performance of the blood purification unit lies within or outside the tolerance range for the expected value.
Owner:FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH

Methods for treatment of refractory generalized myasthenia gravis

ActiveUS12459992B2HaemofiltrationMuscular disorderAntiendomysial antibodiesGeneralized myasthenia
The disclosure provides methods of treating myasthenia gravis (MG) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody.
Owner:ALEXION PHARMACEUTICALS INC

Methods And Systems For High-Throughput Blood Component Collection

Described are embodiments that include methods and devices for separating components from multi-component fluids. Embodiments may involve use of separation vessels and movement of components into and out of separation vessels through ports. Embodiments may involve the separation of plasma from whole blood. Also described are embodiments that include methods and devices for positioning portions, e.g., loops, of disposables in medical devices. Embodiments may involve use of surfaces for automatically guiding loops to position them into a predetermined position.
Owner:TERUMO BCT INC

Combination wearable and stationary dialysis system with ultrafiltrate module

PendingUS20250082830A1HaemofiltrationDialysis systems
The present disclosure includes systems and methods for hemodialysis, such as including a first dialysis module and an auxiliary module detachably connectable to the first dialysis module. The first dialysis module can include a dialyzer, a blood circuit, a dialysate circuit, and a sorbent. The auxiliary module can include an ultrafiltrate collector operably couplable to the dialysate circuit for removing excess fluid therefrom.
Owner:GURA VICTOR

Blood purification method for removing microplastics

The present invention provides a method of removing microplastics from blood or body of a subject, including one or more tissues of the subject, by extracorporeal blood purification, including by plasma exchange, such as double filtration plasma exchange. The present invention also provides a method of treating medical conditions and methods of improving healthy lifespan and lifespan using extracorporeal blood purification, including plasma exchange, such as double filtration plasma exchange, such as by filtering microplastics from blood, and removing microplastics from a tissue or body of a subject, such as a human subject.
Owner:KARIN BARKER MEDICAL CONSULTING INC

Method and apparatus for treating an arterial lesion

One disclosed embodiment comprises a method for treating lesions in the carotid artery of a mammalian body. The method comprises transcervical access and blocking of blood flow through the common carotid artery (with or without blocking of blood flow through the external carotid artery), shunting blood from the internal carotid artery and treating the lesion in the carotid artery.
Owner:BOSTON SCIENTIFIC SCIMED INC

Control systems and methods for blood or fluid handling medical devices

A processor of a medical device configured to communicate with a remote server can be programmed to protect the medical device from exposure to unauthorized or malicious software. A system or method to implement this form of protection can include, for example, at least one processor on the medical device, a control software module that controls the operation of the medical device and is executable on the processor, a data management module that manages data flow to and from the control software module from sources external to the medical device, and an agent module that has access to a limited number of designated memory locations in the medical device. In addition, a hemodialysis apparatus can be configured to operate in conjunction with an apparatus for providing purified water from a source such as a municipal water supply or a well. A system for controlling delivery of purified water to the hemodialysis apparatus can comprise a therapy controller of the hemodialysis apparatus configured to communicate with a controller of a water purification device, and a user interface controller of the hemodialysis apparatus configured to communicate with the therapy controller, and to send data to and receive data from a user interface.
Owner:DEKA PRODUCTS LP

Generating medical fluid for renal replacement therapy

PCT designated stage expiredWO2025011966A1HaemofiltrationDialysis systemsMechanical engineeringKidney replacement
A system is configured to generate a medical fluid for renal replacement therapy by on-line mixing of fluids. The system comprises a first flow path (12), a second flow 5 path (16), a first sensor (20) in the first flow path, and a second sensor (20') in the second flow path. The first and second sensors measure a composition-related parameter. The system is operable to convey at least one of the fluids to the first and second sensors in a calibration phase, and determine a conversion function for converting between a first signal of the first sensor and a second signal of the second 0 sensor, based the first and second signals during the calibration phase. In a production phase, the system is operable to control at least one pump based on converted measurement values given by operating the conversion function on measurement values in the first signal from the first sensor.
Owner:GAMBRO LUNDIA AB

Communications and operation control of apheresis systems

A method includes detecting a startup of an apheresis machine; in response to detecting start up, transmitting data to a server; determining, based on the data, whether software of the apheresis machine is current; receiving, in response to the data, a response from the server; and preventing usage of apheresis machine if the response indicates the software is not current. The data transmitted to the server may include one or more of a data log, a firmware version identifier, and an error log. The response may include a lockout signal. The response may include a software update. The software update may include a firmware update. The method may include automatically initiating installation of the software update. The method may include ceasing prevention of usage of the apheresis machine following installation of the software update.
Owner:TERUMO BCT INC

Continuous blood purification equipment

The invention discloses continuous blood purification equipment, and belongs to the technical field of medical equipment, the continuous blood purification equipment comprises a blood purification assembly, the blood purification assembly comprises a perfusion device, the upper end and the lower end of the perfusion device are fixedly connected with hard insertion ports, a flexible infusion tube is inserted into the hard insertion port in the lower side, and a sealing monitoring assembly is fixedly connected to the flexible infusion tube; the left side wall and the right side wall of the sealing monitoring assembly are provided with two clamping torsion guiding assemblies, the sealing monitoring assembly is communicated with an acousto-optic reminding assembly, and when the flexible infusion tube is separated from the hard inserting opening, the clamping torsion guiding assemblies can be used for automatically sealing the flexible infusion tube; meanwhile, the communicating catheter is opened in cooperation with the clamping and sealing assembly, so that blood can temporarily flow into the communicating catheter, blood pollution can be avoided, blood can be effectively stored, follow-up blood return is facilitated, and negative effects on health of a patient are reduced.
Owner:GUANGZHOU HUALIU MEDICAL TECH CO LTD

Collection, genome editing, and washing of T-cell lymphocytes

Blood from a blood source is drawn into a fluid flow circuit. A mononuclear cell product is separated from the blood, followed by at least a portion of the mononuclear cell product being conveyed into an electroporation device without disconnecting the blood source from the fluid flow circuit. The electroporation device opens pores in a membrane of at least one of the cells of the mononuclear cell product to allow DNA material (which is added to the mononuclear cell product prior to electroporation) to enter and modify the genome of the cell. At least a portion of the modified mononuclear cell product is returned to the blood source. The mononuclear cell product may be washed prior to being conveyed into the electroporation device. The modified mononuclear cell product may be washed after exiting the electroporation device.
Owner:FENWAL INC

Hollow fiber membrane, hollow fiber membrane module and vesicle-containing solution

A hollow fiber membrane, hollow fiber membrane module and vesicle-containing solution that includes a hollow fiber membrane and a hollow fiber membrane module capable of efficiently removing extracellular vesicles (vesicles) from a liquid, particularly from blood. One aspect of the hollow fiber membrane for achieving the above object is a hollow fiber membrane, in which particles having a particle size of 0.15 μm have a permeability of 50% or more and 100% or less, and an average pore size of an inner surface of the hollow fiber membrane is 0.50 μm or more and 3.00 μm or less.
Owner:TORAY INDUSTRIES INC

Systems and methods for peritoneal dialysis with continuous flow

Systems and methods are disclosed for peritoneal dialysis. In an illustrative example, a peritoneal dialysis system can include an input lumen that receives a fluid from a first portion of a peritoneal cavity of a patient. The peritoneal dialysis system includes a filter that filters the fluid to produce a filtered fluid and a waste product. The peritoneal dialysis system includes a mixer that adds a predetermined amount of at least one electrolyte to the filtered fluid to produce a dialysate. The peritoneal dialysis system includes a sensor that measures one or more characteristics of the dialysate, and a controller that compares the one or more characteristics to one or more dialysate characteristic thresholds to verify that the dialysate satisfies one or more rules. The peritoneal dialysis system includes an output lumen that provides the dialysate to a second portion of the peritoneal cavity of the patient.
Owner:KILJANEK LUKASZ R

Disposable components for fluid line autoconnect systems and methods

Components for a medical infusion fluid handling system, such as an APD system, in which one or more lines (such as solution lines), spikes or other connection ports may be automatically capped and / or de-capped. This feature may provide advantages, such as a reduced likelihood of contamination since no human interaction is required to de-cap and connect the lines, spikes or other connections. For example, a fluid handling cassette may include one or more caps that cover a corresponding spike and include a raised and / or recessed feature to assist in removal of the cap from the cassette. A solution line cap may include a hole and recess, groove or other feature to engage with a spike cap and enable removal of the cap.
Owner:DEKA PRODUCTS LP

Systems and methods for optimizing plasma collection volume

The present invention relates to systems and methods for optimizing plasma collection volume. A plasma withdrawal system and a method for operating a plasma withdrawal system are provided by which the volume / weight of the anticoagulated plasma collected is optimized. In one example, a nomogram is provided that utilizes the donor hematocrit to calculate the volume / weight of raw plasma within a plasma product having a maximum volume allowed by the FDA nomogram. In a plasma withdrawal process having multiple collection phases followed by a reinfusion cycle in which concentrated red blood cells are returned to the donor, the volume of plasma product to be collected is calculated prior to the start of each collection cycle to account for the increasing hematocrit of the donor, resulting in a greater total volume of plasma product to be collected during the plasma withdrawal process.
Owner:FENWAL INC

Blood treatment systems and methods

Dialysis systems are disclosed comprising new fluid flow circuits. Systems may include blood and dialysate flow paths, where the dialysate flow path includes balancing, mixing, and / or directing circuits. Dialysate preparation may be decoupled from patient dialysis. Circuits may be defined within one or more cassettes. The fluid circuit fluid flow paths may be isolated from electrical components. A gas supply in fluid communication with the dialysate flow path and / or the dialyzer able to urge dialysate through the dialyzer and urge blood back to the patient may be included for certain emergency situations. Fluid handling devices, such as pumps, valves, and mixers that can be actuated using a control fluid may be included. Control fluid may be delivered by an external pump or other device, which may be detachable and / or generally rigid, optionally with a diaphragm dividing the device into first and second compartments.
Owner:DEKA PRODUCTS LP

Devices for blood capture and reintroduction during aspiration procedure

PendingUS20250222185A1HaemofiltrationMedical devicesBiomedical engineeringAspiration procedure
A blood reintroduction system can include a canister having a chamber configured to collect blood. A system may include an inlet configured to fluidically connect the chamber to a first tubing in fluid communication with an aspiration catheter. A system may include a first filter within the chamber, wherein the first filter is configured to separate blood from thrombus. A system may include a second filter downstream of the first filter, wherein the second filter is configured to separate blood from thrombus. A system may include a second tubing connected to an outlet of the chamber, wherein the second tubing is configured to reintroduce filtered blood from the chamber to a patient's vasculature.
Owner:IMPERATIVE CARE INC

Coronary heart disease treatment filter

The invention discloses a coronary heart disease treatment filter which comprises a filter cartridge with a liquid inlet formed in the upper end and a liquid outlet formed in the lower end. A blood guide plate, a first filter membrane, a second filter membrane and a third filter membrane are sequentially arranged in the filter cartridge from top to bottom at intervals; a blood guide hole penetrating through the upper end surface and the lower end surface of the blood guide plate is formed in the blood guide plate close to the left lower end of the blood guide plate; and the first filter membrane, the second filter membrane and the third filter membrane are obliquely arranged towards the lower right part in the filter cartridge. The device has the beneficial effects that the blood guide plate is used for guiding blood downwards, so that the blood can be prevented from splashing upwards in the filter cartridge as much as possible, and lipid substances in the blood of a patient can be well reduced after the blood conveyed into the filter cartridge is subjected to three-stage filtration through the first filter membrane, the second filter membrane and the third filter membrane; when the treated blood is subsequently transfused back to the blood vessel of a patient, the fat content in the blood is low, and the aggregation of thrombus in the blood vessel of the patient can be well relieved.
Owner:深圳市龙华区中心医院

Methods of treating a cognitive impairment

PCT designated stage expiredWO2025064229A1Nervous disorderHaemofiltration
The disclosure pertains to treating a cognitive impairment, for example, an aging-associated cognitive impairment. In certain aspects, the disclosure describes methods of assaying a sample obtained from a subject having or suspected of having a cognitive impairment for one or more proteins selected from: DLL1, VNN2, VAV3, and SUMF1. In certain embodiments, the cognitive impairment is caused by a neurodegenerative disease, such as Alzheimer's disease. The methods further comprise identifying a subject as likely or not likely to respond positively to the plasma exchange therapy. In even further aspects, the disclosure describes methods for treating a cognitive impairment in the subject by a plasma exchange therapy, wherein based on the specific protein expression data, the subject is identified as likely or not likely to respond positively to the plasma exchange therapy. The plasma exchange therapy can be full and / or low volume plasma exchange. Also provided are kits suitable for performing the methods disclosed herein.
Owner:ALKAHEST INC +1

Extracorporeal circulation system

The invention provides an extracorporeal circulation system which comprises a blood pumping device used for driving blood to flow in the extracorporeal circulation system; the filtering device is used for removing impurities in the blood; the heating device is used for adjusting the temperature of the blood; the gas exchange device is used for adjusting the gas content in the blood; and the monitoring and control system is used for monitoring and controlling operation parameters of the extracorporeal circulation system in real time. According to the system, the blood damage degree can be reduced, the oxygenation efficiency can be improved, and circulation parameters can be accurately controlled and monitored, so that the safety and health of a patient in the extracorporeal circulation process are ensured.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE